X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (218) 218
index medicus (181) 181
animals (169) 169
mice (120) 120
lutetium (118) 118
male (115) 115
tumors (113) 113
cancer (106) 106
lutetium - therapeutic use (102) 102
female (101) 101
oncology (100) 100
radioisotopes (100) 100
lutetium isotopes (90) 90
nuclear medicine (85) 85
radiation therapy (84) 84
radiology, nuclear medicine & medical imaging (83) 83
patients (78) 78
radioisotopes - therapeutic use (78) 78
tissue distribution (69) 69
dosimetry (64) 64
lutetium - administration & dosage (64) 64
medicine & public health (64) 64
imaging / radiology (58) 58
lutetium - chemistry (58) 58
prostate cancer (57) 57
cell line, tumor (56) 56
lutetium - pharmacokinetics (55) 55
neuroendocrine tumors (54) 54
radiopharmaceuticals - therapeutic use (54) 54
peptides (53) 53
radioimmunotherapy (53) 53
middle aged (52) 52
toxicity (52) 52
octreotide - analogs & derivatives (51) 51
metastasis (50) 50
radioisotopes - administration & dosage (50) 50
therapy (49) 49
metastases (46) 46
orthopedics (45) 45
radioisotopes - pharmacokinetics (45) 45
photodynamic therapy (44) 44
radiopharmaceuticals - pharmacokinetics (44) 44
kidneys (43) 43
radiation (42) 42
radionuclide therapy (42) 42
rats (42) 42
cardiology (41) 41
medical imaging (41) 41
prostate (41) 41
aged (40) 40
radioisotopes - chemistry (39) 39
radiopharmaceuticals - administration & dosage (39) 39
radiotherapy (39) 39
somatostatin (39) 39
treatment outcome (39) 39
computed tomography (36) 36
mice, nude (35) 35
adult (32) 32
cancer therapies (31) 31
motexafin lutetium (31) 31
radioimmunotherapy - methods (31) 31
dosimeters (30) 30
octreotide - therapeutic use (30) 30
chemotherapy (29) 29
neuroendocrine tumors - radiotherapy (29) 29
organs (29) 29
care and treatment (28) 28
pharmacology & pharmacy (28) 28
radionuclide imaging (28) 28
single photon emission computed tomography (28) 28
in-vivo (27) 27
lutetium-177 (26) 26
radiotherapy dosage (26) 26
liver (25) 25
lu-177 (25) 25
peptide receptor radionuclide therapy (25) 25
photochemotherapy (25) 25
medicine (24) 24
survival (24) 24
177lu (23) 23
antigens (23) 23
bone marrow (23) 23
radiation dosage (23) 23
radiopharmaceuticals - chemistry (23) 23
prrt (22) 22
tumor (22) 22
antibodies, monoclonal - therapeutic use (21) 21
disease models, animal (21) 21
drug dosages (21) 21
studies (21) 21
medical research (20) 20
medicine, research & experimental (20) 20
pharmacokinetics (20) 20
photosensitizing agents - therapeutic use (20) 20
time factors (20) 20
tomography (20) 20
xenograft model antitumor assays (20) 20
yttrium radioisotopes - therapeutic use (20) 20
biodistribution (19) 19
mice, inbred balb c (19) 19
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Oncology, ISSN 1470-2045, 06/2018, Volume 19, Issue 6, pp. 825 - 833
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2012, Volume 30, Issue 10, pp. 1100 - 1106
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 05/2019, Volume 60
Objectives: Lutathera (lutetium Lu-177 dotatate) was approved for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors... 
Nuclear medicine | Therapy | Radiation effects | Dosimeters | Electronic devices | Medical innovations | Measuring instruments | Exposure | Lutetium | Ionization chambers | Discharge | Radiation dosage | Medicine | Infusion | Language | Radiation measurement | Somatostatin | Dosimetry | Drug dosages | Tumors | Neuroendocrine tumors
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 1/2015, Volume 42, Issue 1, pp. 5 - 19
Journal Article
PloS one, ISSN 1932-6203, 2015, Volume 10, Issue 8, p. e0136204
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 03/2015, Volume 202, pp. 40 - 48
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 11/2018, Volume 15, Issue 11, pp. 4995 - 5004
Increased vascular permeability is an important hallmark of many diseases, including cancer, cerebral ischemia, and severe inflammatory disorders. In this... 
in vivo labeling | bleomycin | vascular leakage | lung injury | transthyretin | albumin | MEDICINE, RESEARCH & EXPERIMENTAL | Sc-44 | BINDER | SERUM-ALBUMIN | AGENT | HSA | POOL | PHARMACOLOGY & PHARMACY | Lu-177 | CLINICAL TRANSLATION | BINDING LIGANDS | PET | Radioisotopes - pharmacokinetics | Tomography, Emission-Computed, Single-Photon - methods | Capillary Permeability | Humans | Lung - diagnostic imaging | Lutetium - administration & dosage | Scandium - chemistry | Tissue Distribution | Heterocyclic Compounds, 1-Ring - chemistry | Scandium - administration & dosage | Female | Lung - metabolism | Lutetium - chemistry | Prealbumin - chemistry | Serum Albumin, Human - chemistry | Bleomycin - toxicity | Disease Models, Animal | Lutetium - pharmacokinetics | Scandium - pharmacokinetics | Acute Lung Injury - diagnostic imaging | Radiopharmaceuticals - chemistry | Radiopharmaceuticals - pharmacokinetics | Mice, Inbred C57BL | Aza Compounds - chemistry | Molecular Imaging - methods | Bleomycin - administration & dosage | Positron-Emission Tomography - methods | Radiopharmaceuticals - administration & dosage | Animals | Acute Lung Injury - chemically induced | Prealbumin - metabolism | Lung - drug effects | Radioisotopes - administration & dosage | Mice | Serum Albumin, Human - metabolism | Lung - blood supply | Radioisotopes - chemistry
Journal Article
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 2014, Volume 41, Issue 8, pp. 1593 - 1602
Pretargeted radioimmunotherapy (PRIT) with bispecific antibodies (bsMAb) and a radiolabeled peptide reduces the radiation dose to normal tissues. Here we... 
Carcinoembryonic antigen | Medicine & Public Health | Orthopedics | Oncology | Nuclear Medicine | Dosimetry | Red bone marrow | Imaging / Radiology | Cardiology | Pretargeted radioimmunotherapy (PRIT) | Bispecific antibodies | LOCK METHOD | HAPTEN-PEPTIDE | HEMATOLOGIC TOXICITY | Red bonemarrow | NUDE-MOUSE MODEL | BISPECIFIC ANTIBODY | NON-HODGKINS-LYMPHOMA | LOW-GRADE | MONOCLONAL-ANTIBODIES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | DOSE-RATE | Humans | Middle Aged | Colorectal Neoplasms - radiotherapy | Tomography, Emission-Computed, Single-Photon | Antibodies, Bispecific - pharmacokinetics | Male | Lutetium - administration & dosage | Haptens - immunology | Oligopeptides - therapeutic use | Heterocyclic Compounds, 1-Ring - administration & dosage | Antibodies, Bispecific - administration & dosage | Adult | Female | Lutetium - therapeutic use | Radiometry - methods | Lutetium - pharmacokinetics | Carcinoembryonic Antigen - immunology | Heterocyclic Compounds, 1-Ring - pharmacokinetics | Oligopeptides - pharmacokinetics | Radioimmunotherapy | Colorectal Neoplasms - diagnostic imaging | Indium Radioisotopes - pharmacokinetics | Radiation Dosage | Antibodies, Bispecific - therapeutic use | Indium Radioisotopes - administration & dosage | Heterocyclic Compounds, 1-Ring - therapeutic use | Indium Radioisotopes - therapeutic use | Aged | Oligopeptides - administration & dosage | Precision Medicine - methods | Cancer patients | Care and treatment | Peptides | Analysis | Colorectal cancer | Nuclear medicine | Radiation therapy | Immunotherapy | Index Medicus
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 11/2015, Volume 217, pp. 170 - 182
Journal Article